The oral delivery of difficult-to-drug molecules, such as peptides, can be achieved using milk-derived extracellular vesicles. The Tiny Cargo Company has established a workflow for the large-scale production of extracellular vesicles from milk for the development of XoLacta — an oral therapy that mitigates the side effects of radiation therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tasdemiroglu, Y., Gourdie, R. G. & He, J. Q. In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases. Eur. J. Pharmacol. 932, 175192 (2022).
Laird, D. W. & Lampe, P. D. Therapeutic strategies targeting connexins. Nat. Rev. Drug Discov. 17, 905–921 (2018).
Montgomery, J. et al. The connexin 43 carboxyl terminal mimetic peptide αCT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin. FASEB J. 35, e21762 (2021).
Jiang, J. et al. Targeting the Cx43 carboxyl terminal H2 domain preserves left ventricular function following ischemia-reperfusion injury. J. Am. Heart Assoc. 8, e012385 (2019).
DiCarlo, A. L. et al. Cutaneous radiation injuries: models, assessment and treatments. Radiat. Res. 194, 315–344 (2020).
Manca, S. et al. Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns. Sci. Rep. 8, 11321 (2018).
Melnik, B. C., Stremmel, W., Weiskirchen, R., John, S. M. & Schmitz, G. Exosome-derived microRNAs of human milk and their effects on infant health and development. Biomolecules 11, 851 (2021).
Marsh, S. R., Pridham, K. J., Jourdan, L. J. & Gourdie, R. G. Novel protocols for scalable production of high quality purified small extracellular vesicles from bovine milk. Nanotheranostics 5, 488–498 (2021).
Marsh, S. R., Jourdan, L. J. & Gourdie, R. G. Bovine milk-derived extracellular vesicles as a novel injury-targeting drug delivery system following cardiac injury. Circulation 146, A11898 (2022).
Mehdi Rashidi, M., Salar Bijari, S., Khazaei, A. H., Shojaei-Ghahrizjani, F. & Rezakhani, L. The role of milk-derived exosomes in the treatment of diseases. Front. Genet. 13, 1009338 (2022).
Anderson, J. W., Johnstone, B. M. & Remley, D. T. Breast-feeding and cognitive development: a meta-analysis. Am. J. Clin. Nutr. 70, 525–535 (1999).
Acknowledgements
Research funded by the National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute (NHLBI) 1R35HL161237-01 and the Redgate Foundation to R.G.G.; by Virginia Catalyst grant 1403 to R.G.G. and S.R.M.; and National Science Foundation (NSF) 2203330 to S.R.M. We wish to express our gratitude to R. Letteri, M. Bannon, D. Montgomery and R. Archer.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
S.R.M. and R.G.G. are company officers and shareholders of The Tiny Cargo Company.
Additional information
Related links
FDA Animal Rule: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/product-development-under-animal-rule
Tiny Cargo: https://www.tinycargo.com/
Rights and permissions
About this article
Cite this article
Marsh, S.R., Gourdie, R.G. Oral delivery of therapeutic peptides by milk-derived extracellular vesicles. Nat Rev Bioeng (2024). https://doi.org/10.1038/s44222-024-00227-9
Published:
DOI: https://doi.org/10.1038/s44222-024-00227-9